Public engagement in health technology assessment in Brazil: the case of the Trastuzumab public consultation

Detalhes bibliográficos
Autor(a) principal: Carvalho, Viviane Karoline da Silva
Data de Publicação: 2019
Outros Autores: Sousa, Maria Sharmila Alina de, Barreto, Jorge Otávio Maia, Silva, Everton Nunes da
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/41602
Resumo: Ministério da Saúde e CAPES
id CRUZ_d4b8ff6c47ca77820e74dfdad13742b7
oai_identifier_str oai:www.arca.fiocruz.br:icict/41602
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Carvalho, Viviane Karoline da SilvaSousa, Maria Sharmila Alina deBarreto, Jorge Otávio MaiaSilva, Everton Nunes da2020-06-10T13:42:57Z2020-06-10T13:42:57Z2019CARVALHO, Viviane Karoline da Silva et al. Public engagement in health technology assessment in Brazil: the case of the Trastuzumab public consultation. BMC Health Services Research, [London], v. 19, n. 762, p. 1-11, 2019.1472-6963https://www.arca.fiocruz.br/handle/icict/4160210.1186/s12913-019-4555-6Ministério da Saúde e CAPESUniversidade de Brasília. Brasília, DF, Brasil.Fundação Oswaldo Cruz. Fiocruz Brasília. Brasília, DF, Brasil.Fundação Oswaldo Cruz. Fiocruz Brasília. Brasília, DF, Brasil.Universidade de Brasília. Brasília, DF, Brasil.Background: Public engagement in health technology assessment (HTA) is increasing worldwide. There are several forms of public engagement and it is not always possible to determine which stakeholders participate in the HTA process and how they contribute. Our objective was to investigate which types of social representatives contributed to the public consultation on the incorporation of Trastuzumab for early-stage breast cancer treatment within the public health system in Brazil, held in 2012 by the National Committee for Health Technology Incorporation (CONITEC). Methods: A mixed methods approach was used to analyze social representativeness and the composition of the corpus from the public consultation, which consisted of 127 contributions. Three types of analysis were performed using IRaMuTeQ software: classic lexical analysis, descending hierarchical classification and specificities analysis. The contributions were clustered according to the main categories of discourse observed, into four social representation categories: 1) patient representation/advocacy; 2) pharmaceutical industry/advocacy; 3) healthcare professionals; and 4) individual contributions. Results: Category 1 contained words related to increased survival due to use of the drug and a low score for words pertaining to studies on Trastuzumab. The word “safety” obtained a positive score only in category 2, which was also the only category that exhibited a negative score for the word “risk”. Category 3 displayed the lowest scores for “diagnosis” and “safety”. The word “efficacy” had a negative score only in category 4. Conclusions: Each category exhibited different results for words related to health systems and to key concepts linked to HTA. Our analysis enabled the identification of the most prominent contributions for each category. Despite the promising results obtained, further research is needed to validate this software for use in analyzing public contributions.engBMC part of Springer NatureBreast NeoplasmsNeoplasm StagingTechnology Assessment, BiomedicalTrastuzumabCommunity ParticipationBrazilAnalytical methodsHealth technology assessment (HTA)Public consultationPublic engagementPublic opinionSocial participationTrastuzumabNeoplasias da MamaEstadiamento de NeoplasiasAvaliação da Tecnologia BiomédicaParticipação da ComunidadePublic engagement in health technology assessment in Brazil: the case of the Trastuzumab public consultationinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-83074https://www.arca.fiocruz.br/bitstream/icict/41602/1/license.txtd3e717dbb24bfc607ede047f44d29a0eMD51ORIGINALve_Viviane_Carvalho_etal.pdfve_Viviane_Carvalho_etal.pdfapplication/pdf1122933https://www.arca.fiocruz.br/bitstream/icict/41602/2/ve_Viviane_Carvalho_etal.pdf18b771602cc78498acb6ac5ebc304b4dMD52TEXTve_Viviane_Carvalho_etal.pdf.txtve_Viviane_Carvalho_etal.pdf.txtExtracted texttext/plain54684https://www.arca.fiocruz.br/bitstream/icict/41602/3/ve_Viviane_Carvalho_etal.pdf.txt8a8ae11ab8b46e52a4e5b55c4fe119d1MD53icict/416022020-12-10 21:39:19.23oai:www.arca.fiocruz.br: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Repositório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352020-12-11T00:39:19Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.pt_BR.fl_str_mv Public engagement in health technology assessment in Brazil: the case of the Trastuzumab public consultation
title Public engagement in health technology assessment in Brazil: the case of the Trastuzumab public consultation
spellingShingle Public engagement in health technology assessment in Brazil: the case of the Trastuzumab public consultation
Carvalho, Viviane Karoline da Silva
Breast Neoplasms
Neoplasm Staging
Technology Assessment, Biomedical
Trastuzumab
Community Participation
Brazil
Analytical methods
Health technology assessment (HTA)
Public consultation
Public engagement
Public opinion
Social participation
Trastuzumab
Neoplasias da Mama
Estadiamento de Neoplasias
Avaliação da Tecnologia Biomédica
Participação da Comunidade
title_short Public engagement in health technology assessment in Brazil: the case of the Trastuzumab public consultation
title_full Public engagement in health technology assessment in Brazil: the case of the Trastuzumab public consultation
title_fullStr Public engagement in health technology assessment in Brazil: the case of the Trastuzumab public consultation
title_full_unstemmed Public engagement in health technology assessment in Brazil: the case of the Trastuzumab public consultation
title_sort Public engagement in health technology assessment in Brazil: the case of the Trastuzumab public consultation
author Carvalho, Viviane Karoline da Silva
author_facet Carvalho, Viviane Karoline da Silva
Sousa, Maria Sharmila Alina de
Barreto, Jorge Otávio Maia
Silva, Everton Nunes da
author_role author
author2 Sousa, Maria Sharmila Alina de
Barreto, Jorge Otávio Maia
Silva, Everton Nunes da
author2_role author
author
author
dc.contributor.author.fl_str_mv Carvalho, Viviane Karoline da Silva
Sousa, Maria Sharmila Alina de
Barreto, Jorge Otávio Maia
Silva, Everton Nunes da
dc.subject.mesh.pt_BR.fl_str_mv Breast Neoplasms
Neoplasm Staging
Technology Assessment, Biomedical
Trastuzumab
Community Participation
Brazil
topic Breast Neoplasms
Neoplasm Staging
Technology Assessment, Biomedical
Trastuzumab
Community Participation
Brazil
Analytical methods
Health technology assessment (HTA)
Public consultation
Public engagement
Public opinion
Social participation
Trastuzumab
Neoplasias da Mama
Estadiamento de Neoplasias
Avaliação da Tecnologia Biomédica
Participação da Comunidade
dc.subject.en.pt_BR.fl_str_mv Analytical methods
Health technology assessment (HTA)
Public consultation
Public engagement
Public opinion
Social participation
dc.subject.decs.pt_BR.fl_str_mv Trastuzumab
Neoplasias da Mama
Estadiamento de Neoplasias
Avaliação da Tecnologia Biomédica
Participação da Comunidade
description Ministério da Saúde e CAPES
publishDate 2019
dc.date.issued.fl_str_mv 2019
dc.date.accessioned.fl_str_mv 2020-06-10T13:42:57Z
dc.date.available.fl_str_mv 2020-06-10T13:42:57Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv CARVALHO, Viviane Karoline da Silva et al. Public engagement in health technology assessment in Brazil: the case of the Trastuzumab public consultation. BMC Health Services Research, [London], v. 19, n. 762, p. 1-11, 2019.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/41602
dc.identifier.issn.pt_BR.fl_str_mv 1472-6963
dc.identifier.doi.none.fl_str_mv 10.1186/s12913-019-4555-6
identifier_str_mv CARVALHO, Viviane Karoline da Silva et al. Public engagement in health technology assessment in Brazil: the case of the Trastuzumab public consultation. BMC Health Services Research, [London], v. 19, n. 762, p. 1-11, 2019.
1472-6963
10.1186/s12913-019-4555-6
url https://www.arca.fiocruz.br/handle/icict/41602
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv BMC part of Springer Nature
publisher.none.fl_str_mv BMC part of Springer Nature
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/41602/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/41602/2/ve_Viviane_Carvalho_etal.pdf
https://www.arca.fiocruz.br/bitstream/icict/41602/3/ve_Viviane_Carvalho_etal.pdf.txt
bitstream.checksum.fl_str_mv d3e717dbb24bfc607ede047f44d29a0e
18b771602cc78498acb6ac5ebc304b4d
8a8ae11ab8b46e52a4e5b55c4fe119d1
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1798325071673032704

Registros relacionados